Incidence of adverse cardiac events 5 years after polymer-free sirolimus eluting stent implantation: Results from the prospective Bad Berka Yukon Choice™ registry-Reference-Cited by-同舟云学术

Incidence of adverse cardiac events 5 years after polymer-free sirolimus eluting stent implantation: Results from the prospective Bad Berka Yukon Choice™ registry

Published:2013-11-12 Issue:7 Volume:84 Page:1080-1086
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Ohlow Marc-Alexander¹,von Korn Hubertus²,Gunkel Oliver³,Farah Ahmed¹,Fuhrmann Joerg T.¹,Lauer Bernward¹

Affiliation:

1. Department of Cardiology; Zentralklinik Bad Berka; Germany

2. Medizinische Klinik 1; Krankenhaus Hetzelstift; Neustadt/Weinstraße Germany

3. Medizinische Klinik 2; Klinikum Frankfurt/Oder; Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.25272/fullpdf

Reference39 articles.

1. Safety and efficacy of drug eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies;Kirtane;Circulation,2009

2. Coronary stents: Current status;Garg;J Am Coll Cardiol,2010

3. Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus the LIPSIA Yukon trial;Desch;JACC Cardiovasc Interv,2011

4. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents;Stone;N Engl J Med,2007

5. Increased restenosis rates 12 months after coronary implantation of the sirolimus-eluting YUKON-choice stent compared to the paclitaxel-eluting TAXUS Stent;Ruef;Clin Cardiol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the era of new-generation drug-eluting stents;Minerva Cardiology and Angiology;2018-05

2. Comparative Case–Control analysis of a dedicated self‐expanding Biolimus A9‐eluting Bifurcation stent versus provisional or mandatory side branch intervention strategies in the treatment of coronary bifurcation lesions;Catheterization and Cardiovascular Interventions;2016-09-21

3. Long-term clinical impact of polymer-free sirolimus-eluting stents in unselected patients;Coronary Artery Disease;2016-08

4. Clinical outcomes of real-world patients treated with an amphilimus polymer-free stent versus new generation everolimus-eluting stents;Catheterization and Cardiovascular Interventions;2015-08-13

5. References;Off-label prescribing - Justifying unapproved medicine;2014-12-19